Related Experiment Video
Updated: Mar 3, 2026

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
Effectiveness of Transdermal Blonanserin Patch for Hyperactive Delirium in Patients with Advanced Cancer Receiving
Yohei Oguri1, Kenji Umeki1, Eiji Ohno2
1Department of Palliative Care, Tenshindo Hetsugi Hospital, Oita, Japan.
Background:
Delirium affects most patients with advanced cancer and is a major source of distress, especially in its hyperactive subtype. Pharmacologic options are limited for patients who cannot take oral medications.
Objectives:
To evaluate the effectiveness and safety of a transdermal blonanserin patch for managing hyperactive delirium in patients with advanced cancer admitted to a palliative care unit.
Design:
Retrospective observational study.
Settings/Subjects:
Consecutive patients with advanced cancer admitted to a palliative care unit in Japan between July 2023 and July 2025. Among 60 patients exhibiting agitation (Richmond Agitation-Sedation Scale-Palliative Version [RASS-PAL] ≥ +1), 21 received a 40-mg blonanserin patch. Eighteen patients who completed the 7-day assessment were analyzed.
Measurements:
The primary endpoint was the change in RASS-PAL score from day 0 to day 7. Safety events and the need for additional antipsychotics were recorded.
Results:
The median RASS-PAL score decreased from 2.0 to 0.5, and the mean score decreased from 1.9 to 0.6 (p = 0.0019). One patient developed reversible excessive sedation. No extrapyramidal symptoms, neuroleptic malignant syndrome, or cardiopulmonary events occurred. The median time from patch initiation to death was 24 days. Five patients required rescue antipsychotics, and no recurrence of the initial severity of delirium was observed.
Conclusions:
The transdermal blonanserin patch appears to be an effective and well-tolerated option for hyperactive delirium in patients with advanced cancer who cannot take oral antipsychotics. Larger prospective studies are warranted to confirm effectiveness and guide optimal use.
Related Concept Videos
Transdermal Drug Delivery Systems
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
